Patent details

EP1337271 Title: COMBINATION OF GABA AGONISTS AND SORBITOL DEHYDROGENASE INHIBITORS

Basic Information

Publication number:
EP1337271
PCT Application Number:
PCT/IB/2001/002213
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019837392
PCT Publication Number:
WO/2002/043762
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF GABA AGONISTS AND SORBITOL DEHYDROGENASE INHIBITORS
French Title of Invention:
COMBINAISON D'AGONISTES GABA ET D'INHIBITEURS DE LA SORBITOL-DESHYDROGENASE (SDI)
German Title of Invention:
KOMBINATION VON GABA AGONISTEN UND SORBITOL DEHYDROGENASE INHIBITOREN
SPC Number:

Dates

Filing date:
19/11/2001
Grant date:
03/11/2004
EP Publication Date:
03/11/2004
PCT Publication Date:
06/06/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/08/2003
EP B1 Publication Date:
03/11/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2005
Expiration date:
19/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/11/2001
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/11/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
MYLARI Banavara Lakshman
Address:
United States (US)

Priority

Priority Number:
250069 P
Priority Date:
30/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;
Filing date Document type Number of pages